DESIGN FOR PHASE-II TESTING OF NEW AGENTS WITHIN A PHASE-III TRIAL WITH CROSSOVER

被引：0
|
作者：
SCHAID, DJ [1 ]
INGLE, JN [1 ]
AHMANN, DL [1 ]
机构：
[1] MAYO CLIN & MAYO FDN,ROCHESTER,MN 55905
来源：
CONTROLLED CLINICAL TRIALS | 1987年 / 8卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：296 / 297
页数：2
相关论文
共 50 条
  • [1] A DESIGN FOR PHASE-II TESTING OF ANTICANCER AGENTS WITHIN A PHASE-III CLINICAL-TRIAL
    SCHAID, DJ
    INGLE, JN
    WIEAND, S
    AHMANN, DL
    CONTROLLED CLINICAL TRIALS, 1988, 9 (02): : 107 - 118
  • [2] APPLICABILITY OF PHASE-I TRIAL RESULTS IN THE DESIGN OF PHASE-II AND PHASE-III BIOLOGICAL RESPONSE MODIFIER TRIALS
    PINSKY, CM
    CANCER TREATMENT REPORTS, 1985, 69 (10): : 1171 - 1176
  • [3] RATE OF POLYMORPHIC TRANSFORMATION BETWEEN PHASE-II AND PHASE-III OF HEXACHLOROETHANE
    KOGA, Y
    MIURA, RM
    JOURNAL OF THE CHEMICAL SOCIETY-FARADAY TRANSACTIONS I, 1978, 74 : 1913 - 1921
  • [4] BRAIN-TUMOR CHEMOTHERAPY - AN EVALUATION OF AGENTS IN CURRENT USE FOR PHASE-II AND PHASE-III TRIALS
    EDWARDS, MS
    LEVIN, VA
    WILSON, CB
    CANCER TREATMENT REPORTS, 1980, 64 (12): : 1179 - 1205
  • [5] LOCALLY ADVANCED BREAST-CANCER - REPORT OF PHASE-II STUDY AND SUBSEQUENT PHASE-III TRIAL
    RODGER, A
    JACK, WJL
    HARDMAN, PDJ
    KERR, GR
    CHETTY, U
    LEONARD, RCF
    BRITISH JOURNAL OF CANCER, 1992, 65 (05) : 761 - 765
  • [6] REMISSION IN PHASE-II AND PHASE-III CLINICAL-TRIALS - CRITERIA AND PREREQUISITES
    EDLER, L
    FLECHTNER, H
    ONKOLOGIE, 1987, 10 (06): : 330 - 339
  • [7] PHASE-II AND PHASE-III STUDIES WITH CARBOPLATIN (JM8, CBDCA)
    CALVERT, AH
    WILTSHAW, E
    BAKER, JW
    SMITH, IE
    INVESTIGATIONAL NEW DRUGS, 1984, 2 (01) : 105 - 105
  • [8] THE CLINICAL-EVALUATION OF CANCER CHEMOPREVENTION AGENTS - DEFINING AND CONTRASTING PHASE-I, PHASE-II, AND PHASE-III OBJECTIVES
    GOODMAN, GE
    CANCER RESEARCH, 1992, 52 (09) : S2752 - S2757
  • [9] CARBOPLATIN AND IFOSFAMIDE IN OVARIAN-CANCER PHASE-II AND PHASE-III TRIALS
    WILTSHAW, E
    PERREN, TJ
    FRYATT, ID
    BLAKE, PR
    HARPER, P
    SLEVIN, M
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1990, 26 : S48 - S50
  • [10] TREATMENT OF HIGH-GRADE NON-HODGKIN LYMPHOMA - RESULTS OF A PHASE-II AND A PHASE-III TRIAL
    KOPPLER, H
    PFLUGER, KH
    HAVEMANN, K
    ESCHENBACH, I
    PFAB, R
    LENNERT, K
    WELLENS, W
    SCHMIDT, M
    GASSEL, WD
    KOLB, R
    HASSLER, R
    SCHUMACHER, K
    VONSPETH, G
    GROPP, C
    HIRSCHMANN, WD
    GOSSMANN, HH
    OHL, S
    DRINGS, P
    HOSSFELD, DK
    BRUNTSCH, U
    BLUT, 1988, 57 (04): : 220 - 220
12345